Abstract
Percutaneous CT- and ultrasound-guided radiofrequency ablation of renal cell carcinoma (RCC) has been shown to have very promising medium-term results. We present a unique case of recurrent RCC after partial nephrectomy in a patient with a single kidney and impaired renal function. This tumor could not be visualized either with CT or with ultrasound. A combination of magnetic resonance imaging and fluoroscopic guidance was used, to the best of our knowledge for the first time, to ablate the tumor with radiofrequency. The patient was cancer-free and off dialysis at 30-month follow up.
Similar content being viewed by others
References
Breen DJ, Rutherford EE, Stedman B et al (2007) Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors. CardioVasc Interv Radiol 30(5):936–942
Zagoria RJ, Traver MA, Welre DM et al (2007) Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR 189:429–436
Veltri A, Calvo A, Tosetti I et al (2006) Experiences in US-guided percutaneous radiofrequency ablation of 44 renal tumours in 31 patients: analysis of predictors for complications and technical success. CardioVasc Interv Radiol 29(5):811–818
Lewin JS, Gamal Nour S, Connell CF et al (2004) Phase II clinical trial of interactive MR imaging-guided interstitial radiofrequency thermal ablation of primary kidney tumours: initial experience. Radiology 232:835–845
Fergany AF, Saad IR, Woo L, Novick AC (2006) Open partial nephrectomy for tumor in a solitary kidney: experience with 400 Cases. J Urol 175:1630–1633
Bosniak MA, Birnbaum BA, Krinsky GA, Waisman J (1995) Small renal parenchymal neoplasms; further observations on growth. Radiology 197:589–597
Gervais DA, McGovern FJ, Arellano RS et al (2005) Radiofrequency ablation of renal cell carcinoma: part I, indications, results and role in patient management over a 6–year period and ablation of 100 tumors. AJR 185:64–71
Fotiadis NI, Sabharwal T, Morales JP, Hodgson DJ, O’Brien TS, Adam A (2007) Combined percutaneous radiofrequency ablation and ethanol injection of renal tumours; midterm results. Eur Urol 52(3):777–784
Adam A, Hatzidakis A, Hamady M et al (2004) Percutaneous coil placement prior to radiofrequency ablation of poorly visible hepatic tumours. Eur Radiol 14:1688–1691
Medicines and Healthcare Products Regulatory Agency, Commission on Human Medicines (2007) Nephrogenic systemic fibrosis (NSF) with gadolinium-containing magnetic resonance imaging (MRI) contrast agents: update. Available at: http://www.mhra.gov.uk/home/idcplg?IdcService = SS_GET_PAGE&useSecondary = true&ssDocName = CON2031543&ssTargetNodeId = 221. Accessed October 28, 2007
Jacobsohn KM, Ahrar K, Wood CG, Matin SF (2007) Is radiofrequency ablation safe for solitary kidneys? Urology (in press)
LinksGebauer B, Werk M, Lopez-Hänninen E et al (2007) Radiofrequency ablation in combination with embolization in metachronous recurrent renal cancer in solitary kidney after contralateral tumor nephrectomy. CardioVasc Interv Radiol 30(4):644–649
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fotiadis, N.I., Sabharwal, T., Gangi, A. et al. Combined MRI and Fluoroscopic Guided Radiofrequency Ablation of a Renal Tumor. Cardiovasc Intervent Radiol 32, 184–187 (2009). https://doi.org/10.1007/s00270-008-9334-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-008-9334-4